Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Celecoxib vs. Acetaminophen-codeine-caffeine for Postoperative Pain in Primary Elective Open Septorhinoplasty With Osteotomies: a Randomized Controlled Trial.

NCT04259333 is registered in ClinicalTrials.gov with Blake Raggio as lead sponsor.

NCT NCT04259333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04259333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Celecoxib vs. Acetaminophen-codeine-caffeine for Postoperative Pain in Primary Elective Open Septorhinoplasty With Osteotomies: a Randomized Controlled Trial.
Lead sponsor
Blake Raggio
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2020
Completion date
December 1, 2020
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid analgesic adverse reaction, opioid use, pain, postoperative, surgery--complications